![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessEarly combination therapy of COVID-19 in high-risk patients
Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been observed in immunocompromised hosts. Early monotherapy with direct-acting antivirals or monoclonal antibodies, as rec...
-
Article
Open AccessComparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron—results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP)
The influence of new SARS-CoV-2 variants on the post-COVID-19 condition (PCC) remains unanswered. Therefore, we examined the prevalence and predictors of PCC-related symptoms in patients infected with the SARS...
-
Article
Open AccessHemophagocytic lymphohistiocytosis—how common and how severe is it as a complication of malaria? Retrospective case series and review of the literature
Infection-associated secondary hemophagocytic lymphohistiocytosis (sHLH) is a potentially life-threatening hyperinflammatory condition caused by various infectious diseases. Malaria has rarely been described a...
-
Article
Open AccessAIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999–2018
This study examined the characteristics, incidence and prognostic factors of the first AIDS-defining condition developed after more than one year of continuous antiretroviral therapy (ART) among people living ...
-
Article
Erratum zu: OMW: HIV Postexpositionsprophylaxe in der Notaufnahme. Wann einleiten?
-
Article
HIV-Postexpositionsprophylaxe in der Notaufnahme: Vorgehen, Tipps & Tricks
In zentralen Notaufnahmen stellen sich regelmäßig Patienten nach vermutetem oder gesichertem Kontakt mit dem humanen Immundefizienzvirus (HIV) vor, um dort bezüglich der Indikation einer Postexpositionsprophyl...
-
Article
Open AccessHIV-Postexpositionsprophylaxe in der Notaufnahme: Vorgehen, Tipps & Tricks
In zentralen Notaufnahmen stellen sich regelmäßig Patienten nach vermutetem oder gesichertem Kontakt mit dem humanen Immundefizienzvirus (HIV) vor, um dort bezüglich der Indikation einer Postexpositionsprophyl...
-
Article
Open AccessEuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project
Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), can lead to hospitalisation, particularly in elderly, immunocompromised, and non-vac...
-
Article
Open AccessTecovirimat for the treatment of severe Mpox in Germany
In May 2022, a multi-national mpox outbreak was reported in several non-endemic countries. The only licensed treatment for mpox in the European Union is the orally available small molecule tecovirimat, which in O...
-
Article
OMW: HIV Postexpositionsprophylaxe in der Notaufnahme. Wann einleiten?
-
Article
Open AccessUse and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study
The use of remdesivir (RDV) as the first drug approved for coronavirus disease 2019 (COVID-19) remains controversial. Based on the Lean European Open Survey on severe acute respiratory syndrome coronavirus-2 (...
-
Article
Open AccessIn-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
Despite scientific evidence originating from two patients published to date that CCR5Δ32/Δ32 hematopoietic stem cell transplantation (HSCT) can cure human immunodeficiency virus type 1 (HIV-1), the knowledge o...
-
Article
Open AccessPercutaneous fractionated radiotherapy of the groin to eliminate lymphatic fistulas after vascular surgery
Vascular surgery of the inguinal area can be complicated by persistent lymphatic fistulas. Rapid and effective treatment is essential to prevent infection, sepsis, bleeding, and possible leg amputation. Curren...
-
Article
Open AccessPrognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection
The presentation of peptides and the subsequent immune response depend on the MHC characteristics and influence the specificity of the immune response. Several studies have found an association between HLA var...
-
Article
Open AccessObesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients
Metabolic disorders have been identified as major risk factors for severe acute courses of COVID-19. With decreasing numbers of infections in many countries, the long COVID syndrome (LCS) represents the next m...
-
Article
Open AccessRecurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with uncontrolled activation of lymphocytes and macrophages. Besides a primary (genetic) form, HLH can also be triggered by malignant, ...
-
Article
Open AccessAcute cardiac side effects after COVID-19 mRNA vaccination: a case series
Vaccination against SARS-CoV-2 has been the main tool to contain the pandemic. The rush development of the 3 vaccines and their expedited approval have led to inoculation of millions of patients around the wor...
-
Article
Correction to: Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018
A correction to this paper has been published: https://doi.org/10.1007/s15010-021-01627-4
-
Article
Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018
Castleman’s disease (CD) is a well-established entity but there is a lack of available data regarding the management and therapy of HIV- and HHV-8-positive multicentric CD (MCD). We provide our own single-cent...
-
Article
Open AccessDelayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction
The coronavirus disease 2019 (COVID‐19) is associated with a wide clinical spectrum of skin manifestations, including urticarial, vesicular, vasculitic and chilblain‐like lesions. Recently, delayed skin reacti...